Reports
Reports
Analyst Viewpoint
Increase in prevalence of anemia and rise in geriatric population are driving the hematocrit test devices market size. Point-of-care hematocrit devices are gaining traction as they offer highly accurate measurements for blood donor screening. Rise in awareness regarding anemia is also boosting the demand for hematocrit test devices.
Growth in focus on health and fitness is likely to offer lucrative opportunities to vendors in the hematocrit test devices market landscape.
Key players are introducing cutting-edge solutions that improve the precision, effectiveness, and accessibility of hematocrit testing. They are also forging strategic alliances to expand their global footprint.
Hematocrit test devices are frequently employed to determine the proportion of red blood cells in an individual's blood volume. Hematocrit test is crucial for the diagnosis of illnesses such as polycythemia, anemia, and dehydration.
It is also used to track the effectiveness of specific medical therapies. Hematocrit test instruments are frequently utilized in diagnostic labs, hospitals, and clinics.
Hematocrit testing equipment are employed in hospitals for regular blood check-ups, blood condition diagnoses (including anemia), and patient care monitoring. These tools are also used by clinics for rapid and precise blood analysis.
| Attribute | Detail |
|---|---|
| Drivers |
|
Hematocrit test is a simple blood test that determines the proportion of red blood cells. A hematocrit level that is below the normal range, indicating inadequate red blood cells, is referred to as anemia. As a result, the hematocrit test is crucial for identifying anemia.
Growth in incidence of anemia is fueling the hematocrit test devices market development. According to the Indian government's fifth round of the National Family Health Survey (NFHS-5) of 2019–21, released in March 2022, at least 67% of children (6–59 months) suffer from anemia, up from 58.6% in the previous survey carried out in 2015–16.
Rise in awareness regarding anemia is expected to spur the hematocrit test devices market growth in the near future. In May 2021, the Women and Child Development Department launched the 'Anemia Campaign 12' in India to boost awareness about low hemoglobin levels in women and children.
The need for hematocrit tests is anticipated to rise due to an aging population as they are more likely to develop chronic illnesses and need frequent check-ups. As per the UN World Population Prospects 2022, the proportion of the world's population that is 65 years of age or older is expected to increase from 10% in 2022 to 16% by 2050.
Additionally, it is predicted that by 2050, there will be roughly the same number of children under the age of twelve and more than twice as many people over the age of 65 worldwide.
Growth in focus on health and fitness is driving the hematocrit test devices market demand. People are becoming more proactive in tracking their blood health and early detection of potential health issues.
Hematocrit test devices are preferred by individuals around the world due to technological developments such as hematology analyzers and point-of-care diagnostic equipment.
These test devices are easily performed and give accurate results. Automated hematocrit measurement tools shorten diagnosis turnaround times and increase patient care by producing fast and reliable results.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America held the largest market share in 2022. Increase in cases of blood-related disorders, well-developed healthcare infrastructure, and presence of major key players are some of the major factors propelling the hematocrit test devices market share in the region.
According to the latest hematocrit test devices market trends, the U.S. is anticipated to hold major share due to the presence of well-developed medical infrastructure and increase in geriatric population.
In 2022, the Hematology Journal stated that anemia is becoming more common in the U.S. Anemia affects African Americans three times more frequently than it does white people. In 2022, the Centers for Disease Control and Prevention (CDC) stated that about 890,000 visits to emergency departments with anemia were recorded in the U.S. in 2021.
Major players are concentrating on providing a wide range of testing options to meet the growth in demand and obtain a competitive edge over other companies. They are also introducing cutting-edge solutions that improve the precision, effectiveness, and accessibility of hematocrit testing.
Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers (Siemens AG), EKF Diagnostics Holdings plc, Sysmex Corporation, Nova Biomedical, Abbott, HORIBA, Ltd., and Boule Diagnostics are key players operating in this hematocrit test devices industry.
Each of these companies has been profiled in the hematocrit test devices market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 5.1 Bn |
| Market Forecast (Value) in 2031 | US$ 7.0 Bn |
| Growth Rate (CAGR) | 3.4% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 5.1 Bn in 2022
It is anticipated to grow at a CAGR of 3.4% from 2023 to 2031
Increase in prevalence of anemia and rise in geriatric population
North America was the leading region in 2022
Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers (Siemens AG), EKF Diagnostics Holdings plc, Sysmex Corporation, Nova Biomedical, Abbott, HORIBA, Ltd., and Boule Diagnostics
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hematocrit Test Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hematocrit Test Devices Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Hematocrit Test Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Blood Analyzers
6.3.2. Hematocrit Test Meters
6.3.3. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Hematocrit Test Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals & Ambulatory Surgical Centers
7.3.2. Clinics
7.3.3. Diagnostic & Pathology Labs
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Hematocrit Test Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Hematocrit Test Devices Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Product, 2017–2031
9.3.1. Blood Analyzers
9.3.2. Hematocrit Test Meters
9.3.3. Others
9.4. Market Value Forecast, by End-user, 2017–2031
9.4.1. Hospitals & Ambulatory Surgical Centers
9.4.2. Clinics
9.4.3. Diagnostic & Pathology Labs
9.4.4. Others
9.5. Market Value Forecast, by Country, 2017–2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By End-user
9.6.3. By Country
10. Europe Hematocrit Test Devices Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Blood Analyzers
10.3.2. Hematocrit Test Meters
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals & Ambulatory Surgical Centers
10.4.2. Clinics
10.4.3. Diagnostic & Pathology Labs
10.4.4. Others
10.5. Market Value Forecast, by Country/Sub-region, 2017–2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Hematocrit Test Devices Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Blood Analyzers
11.3.2. Hematocrit Test Meters
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals & Ambulatory Surgical Centers
11.4.1.1. Clinics
11.4.1.2. Diagnostic & Pathology Labs
11.4.1.3. Others
11.4.2. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.3. China
11.4.4. Japan
11.4.5. India
11.4.6. Australia & New Zealand
11.4.7. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Hematocrit Test Devices Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Blood Analyzers
12.3.2. Hematocrit Test Meters
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals & Ambulatory Surgical Centers
12.4.2. Clinics
12.4.3. Diagnostic & Pathology Labs
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Hematocrit Test Devices Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Blood Analyzers
13.3.2. Hematocrit Test Meters
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals & Ambulatory Surgical Centers
13.4.2. Clinics
13.4.3. Diagnostic & Pathology Labs
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Nihon Kohden Corporation
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. F. Hoffmann-La Roche Ltd.
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Danaher Corporation
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Siemens Healthineers (Siemens AG)
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. EKF Diagnostics Holdings plc
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Sysmex Corporation
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Nova Biomedical
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Abbott
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. HORIBA, Ltd.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. Boule Diagnostics
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview
List of Tables
Table 01: Global Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Hematocrit Test Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 06: North America Hematocrit Test Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Europe Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 09: Europe Hematocrit Test Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 10: Asia Pacific Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 12: Asia Pacific Hematocrit Test Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Latin America Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Latin America Hematocrit Test Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Middle East & Africa Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa Hematocrit Test Devices Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Middle East & Africa Hematocrit Test Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Hematocrit Test Devices Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Hematocrit Test Devices Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Hematocrit Test Devices Market Value Share, by Product, 2022
Figure 04: Global Hematocrit Test Devices Market Revenue (US$ Mn), by End-user, 2022
Figure 05: Global Hematocrit Test Devices Market Value Share, by End-user, 2022
Figure 06: Global Hematocrit Test Devices Market Value Share, by Region, 2022
Figure 07: Global Hematocrit Test Devices Market Value (US$ Mn) Forecast, 2023–2031
Figure 08: Global Hematocrit Test Devices Market Value Share Analysis, by Product, 2022–2031
Figure 09: Global Hematocrit Test Devices Market Attractiveness Analysis, by Product, 2023–2031
Figure 10: Global Hematocrit Test Devices Market Value Share Analysis, by End-user, 2022–2031
Figure 11: Global Hematocrit Test Devices Market Attractiveness Analysis, by End-user, 2023–2031
Figure 12: Global Hematocrit Test Devices Market Value Share Analysis, by Region, 2022–2031
Figure 13: Global Hematocrit Test Devices Market Attractiveness Analysis, by Region, 2023–2031
Figure 14: North America Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 15: North America Hematocrit Test Devices Market Attractiveness Analysis, by Country, 2023–2031
Figure 16: North America Hematocrit Test Devices Market Value Share Analysis, by Country, 2022–2031
Figure 17: North America Hematocrit Test Devices Market Value Share Analysis, by Product, 2022–2031
Figure 18: North America Hematocrit Test Devices Market Value Share Analysis, by End-user, 2022–2031
Figure 19: North America Hematocrit Test Devices Market Attractiveness Analysis, by Product, 2023–2031
Figure 20: North America Hematocrit Test Devices Market Attractiveness Analysis, by End-user, 2023–2031
Figure 21: Europe Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 22: Europe Hematocrit Test Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 23: Europe Hematocrit Test Devices Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 24: Europe Hematocrit Test Devices Market Value Share Analysis, by Product, 2022–2031
Figure 25: Europe Hematocrit Test Devices Market Value Share Analysis, by End-user, 2022–2031
Figure 26: Europe Hematocrit Test Devices Market Attractiveness Analysis, by Product, 2023–2031
Figure 27: Europe Hematocrit Test Devices Market Attractiveness Analysis, by End-user, 2023–2031
Figure 28: Asia Pacific Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 29: Asia Pacific Hematocrit Test Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 30: Asia Pacific Hematocrit Test Devices Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 31: Asia Pacific Hematocrit Test Devices Market Value Share Analysis, by Product, 2022–2031
Figure 32: Asia Pacific Hematocrit Test Devices Market Value Share Analysis, by End-user, 2022–2031
Figure 33: Asia Pacific Hematocrit Test Devices Market Attractiveness Analysis, by Product, 2023–2031
Figure 34: Asia Pacific Hematocrit Test Devices Market Attractiveness Analysis, by End-user, 2023–2031
Figure 35: Latin America Hematocrit Test Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 36: Latin America Hematocrit Test Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 37: Latin America Hematocrit Test Devices Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 38: Latin America Hematocrit Test Devices Market Value Share Analysis, by Product, 2022–2031
Figure 39: Latin America Hematocrit Test Devices Market Value Share Analysis, by End-user, 2022–2031
Figure 40: Latin America Hematocrit Test Devices Market Attractiveness Analysis, by Product, 2023–2031
Figure 41: Latin America Hematocrit Test Devices Market Attractiveness Analysis, by End-user, 2023–2031
Figure 42: Middle East & Africa Hematocrit Test Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 43: Middle East & Africa Hematocrit Test Devices Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 44: Middle East & Africa Hematocrit Test Devices Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 45: Middle East & Africa Hematocrit Test Devices Market Value Share Analysis, by Product, 2022–2031
Figure 46: Middle East & Africa Hematocrit Test Devices Market Value Share Analysis, by End-user, 2022–2031
Figure 47: Middle East & Africa Hematocrit Test Devices Market Attractiveness Analysis, by Product, 2023–2031
Figure 48: Middle East & Africa Hematocrit Test Devices Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Hematocrit Test Devices Market